Table 2. DisMod II output for males and females- age-specific incidence, prevalence, remission, duration and standardized mortality rates, Agincourt 2008–2012.
| Age band (in years) | Incidence per 100,000 (95%UI) | Prevalence per 1,000 (95%UI) | Remission per 100 (95%UI) | Duration in years (95%UI) | Standardized Mortality Rate (95%UI) |
|---|---|---|---|---|---|
| Male | |||||
| 0–5 | 30.1 (27.7–32.6) | 1.4 (1.2–1.6) | 16.0 (14.8–17.1) | 12.0 (11.3–12.7) | 7.7 (7.3–8.1) |
| 6–12 | 23.6 (21.8–25.4) | 1.9 (1.6–2.2) | 3.3 (3.1–3.6) | 18.4 (17.3–19.4) | 20.2 (19.3–21.2) |
| 13–18 | 15.0 (13.6–16.4) | 2.6 (2.3–2.9) | 4.5 (4.2–4.8) | 16.5 (15.5–17.5) | 11.5 (11.0–12.2) |
| 19–28 | 15.0 (13.8–16.2) | 1.9 (1.6–2.3) | 9.3 (8.8–9.8) | 26.0 (24.6–27.4) | 1.9 (1.8–2.0) |
| 29–49 | 16.9 (15.7–18.2) | 3.3 (3.0–3.6) | 0.0 (0.0–0.1) | 32.0 (30.1–33.8) | 2.0 (1.9–2.1) |
| 50+ | 19.7 (18.3–21.2) | 5.6 (5.1–6.0) | 2.0 (1.6–2.4) | 25.3 (22.3–28.5) | 3.6 (3.4–3.7) |
| All ages | 19.4 (17.9–21.0) | 2.6 (2.3–2.9) | 4.6 (4.1–5.0) | 21.5 (20.1–22.8) | 8.2 (7.9–8.7) |
| Female | |||||
| 0–5 | 16.0 (13.1–18.0) | 0.4 (0.3–0.5) | 30.5 (28.5–32.6) | 10.6 (10.11.3) | 1.0 (1.0–1.0) |
| 6–12 | 19.3 (17.2–20.2) | 0.9 (0.7–1.0) | 6.6 (5.6–7.3) | 28.2 (26.7–29.6) | 1.0 (1.0–1.0) |
| 13–18 | 17.8 (16.2–18.8) | 1.9 (1.7–2.1) | 0.4 (0.2–0.6) | 27.2 (25.8–28.7) | 3.7 (3.6–4.0) |
| 19–28 | 13.0 (11.9–14.1) | 2.8 (2.5–3.0) | 1.3 (0.9–1.7) | 22.4 (21.3–23.6) | 2.7 (2.8–2.9) |
| 29–49 | 16.1 (15.0–17.4) | 3.9 (3.5–4.2) | 3.1 (2.8–3.4) | 16.6 (15.7–17.5) | 1.3 (1.1–1.4) |
| 50+ | 24.2 (22.4–26.0) | 3.6 (3.3–3.9) | 6.5 (6.0–7.0) | 14.2 (13.1–15.3) | 1.7 (1.6–1.7) |
| All ages | 17.2 (15.5–18.5) | 2.4 (2.2–2.7) | 3.9 (3.4–4.5) | 19.7 (18.7–20.7) | 2.6 (2.5–2.7) |